RxDoctor Payments Data

Katie Sternberg

Family · Kirksville, MONPI 1942859434

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 25.2% of the total. Reporting peaked in 2021 at $441 and has fallen 94.0% since, to $26 in 2025.

$1,360in general payments, 2019–2025

Across 86 payments — averaging $15.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$342
  • Novo Nordisk$124
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$119
  • Dexcom, Inc.$90
  • Amgen$86
  • Otsuka America Pharmaceutical, Inc.$74
  • plus $525 from 17 others

What the payments were for

  • Food & beverage$1,360100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,360 in reported general payments places this provider in the 70th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri →

Other family in Kirksville

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →